BESORFIB Trademark

Trademark Overview


On Monday, January 9, 2017, a trademark application was filed for BESORFIB with the United States Patent and Trademark Office. The USPTO has given the BESORFIB trademark a serial number of 87293657. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 20, 2020. This trademark is owned by Pfizer Inc.. The BESORFIB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
besorfib

General Information


Serial Number87293657
Word MarkBESORFIB
Filing DateMonday, January 9, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 20, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 16, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, July 20, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 20, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 6, 2019EXTENSION 5 GRANTED
Wednesday, December 4, 2019EXTENSION 5 FILED
Friday, December 6, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 4, 2019TEAS EXTENSION RECEIVED
Saturday, May 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2019EXTENSION 4 GRANTED
Thursday, May 16, 2019EXTENSION 4 FILED
Thursday, May 16, 2019TEAS EXTENSION RECEIVED
Wednesday, November 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 19, 2018EXTENSION 3 GRANTED
Monday, November 19, 2018EXTENSION 3 FILED
Monday, November 19, 2018TEAS EXTENSION RECEIVED
Wednesday, May 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 21, 2018EXTENSION 2 GRANTED
Monday, May 21, 2018EXTENSION 2 FILED
Monday, May 21, 2018TEAS EXTENSION RECEIVED
Saturday, November 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 2, 2017EXTENSION 1 GRANTED
Thursday, November 2, 2017EXTENSION 1 FILED
Thursday, November 2, 2017TEAS EXTENSION RECEIVED
Tuesday, June 13, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 2, 2017ASSIGNED TO EXAMINER
Monday, January 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 12, 2017NEW APPLICATION ENTERED IN TRAM